nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Digestion impaired—Methoxsalen—psoriasis	0.039	0.039	CcSEcCtD
Phenazopyridine—Calculus of kidney—Calcitriol—psoriasis	0.0354	0.0354	CcSEcCtD
Phenazopyridine—Nephrolithiasis—Calcitriol—psoriasis	0.0289	0.0289	CcSEcCtD
Phenazopyridine—Meningitis aseptic—Methotrexate—psoriasis	0.0258	0.0258	CcSEcCtD
Phenazopyridine—Digestion impaired—Hydroxyurea—psoriasis	0.0242	0.0242	CcSEcCtD
Phenazopyridine—Digestion impaired—Cyclosporine—psoriasis	0.0164	0.0164	CcSEcCtD
Phenazopyridine—Visual disturbance—Acitretin—psoriasis	0.0158	0.0158	CcSEcCtD
Phenazopyridine—Visual disturbance—Fluocinolone Acetonide—psoriasis	0.0158	0.0158	CcSEcCtD
Phenazopyridine—Hypersensitivity—Calcipotriol—psoriasis	0.0154	0.0154	CcSEcCtD
Phenazopyridine—Pruritus—Calcipotriol—psoriasis	0.0148	0.0148	CcSEcCtD
Phenazopyridine—Rash—Calcipotriol—psoriasis	0.0132	0.0132	CcSEcCtD
Phenazopyridine—Dermatitis—Calcipotriol—psoriasis	0.0132	0.0132	CcSEcCtD
Phenazopyridine—Jaundice—Acitretin—psoriasis	0.0113	0.0113	CcSEcCtD
Phenazopyridine—Pruritus—Tazarotene—psoriasis	0.0109	0.0109	CcSEcCtD
Phenazopyridine—Hepatitis—Acitretin—psoriasis	0.0104	0.0104	CcSEcCtD
Phenazopyridine—Visual impairment—Acitretin—psoriasis	0.00999	0.00999	CcSEcCtD
Phenazopyridine—Visual impairment—Fluocinolone Acetonide—psoriasis	0.00996	0.00996	CcSEcCtD
Phenazopyridine—Rash—Tazarotene—psoriasis	0.0097	0.0097	CcSEcCtD
Phenazopyridine—Dermatitis—Tazarotene—psoriasis	0.0097	0.0097	CcSEcCtD
Phenazopyridine—Hypersensitivity—Clobetasol propionate—psoriasis	0.00961	0.00961	CcSEcCtD
Phenazopyridine—Pruritus—Clobetasol propionate—psoriasis	0.00923	0.00923	CcSEcCtD
Phenazopyridine—Hypersensitivity—Fluocinonide—psoriasis	0.00867	0.00867	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Mycophenolate mofetil—psoriasis	0.00861	0.00861	CcSEcCtD
Phenazopyridine—Visual disturbance—Cyclosporine—psoriasis	0.00841	0.00841	CcSEcCtD
Phenazopyridine—Pruritus—Fluocinonide—psoriasis	0.00833	0.00833	CcSEcCtD
Phenazopyridine—Rash—Clobetasol propionate—psoriasis	0.00823	0.00823	CcSEcCtD
Phenazopyridine—Dermatitis—Clobetasol propionate—psoriasis	0.00822	0.00822	CcSEcCtD
Phenazopyridine—Visual disturbance—Mycophenolate mofetil—psoriasis	0.00821	0.00821	CcSEcCtD
Phenazopyridine—Dyspepsia—Methoxsalen—psoriasis	0.00818	0.00818	CcSEcCtD
Phenazopyridine—Headache—Clobetasol propionate—psoriasis	0.00817	0.00817	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Methoxsalen—psoriasis	0.00802	0.00802	CcSEcCtD
Phenazopyridine—Visual disturbance—Prednisolone—psoriasis	0.00766	0.00766	CcSEcCtD
Phenazopyridine—Rash—Beclomethasone—psoriasis	0.00749	0.00749	CcSEcCtD
Phenazopyridine—Dermatitis—Beclomethasone—psoriasis	0.00748	0.00748	CcSEcCtD
Phenazopyridine—Headache—Beclomethasone—psoriasis	0.00744	0.00744	CcSEcCtD
Phenazopyridine—Rash—Fluocinonide—psoriasis	0.00742	0.00742	CcSEcCtD
Phenazopyridine—Dermatitis—Fluocinonide—psoriasis	0.00741	0.00741	CcSEcCtD
Phenazopyridine—Jaundice—Mycophenolic acid—psoriasis	0.0074	0.0074	CcSEcCtD
Phenazopyridine—Headache—Fluocinonide—psoriasis	0.00737	0.00737	CcSEcCtD
Phenazopyridine—Nausea—Beclomethasone—psoriasis	0.00706	0.00706	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methoxsalen—psoriasis	0.00684	0.00684	CcSEcCtD
Phenazopyridine—Hepatitis—Mycophenolic acid—psoriasis	0.00682	0.00682	CcSEcCtD
Phenazopyridine—Pruritus—Methoxsalen—psoriasis	0.00657	0.00657	CcSEcCtD
Phenazopyridine—Visual impairment—Mycophenolic acid—psoriasis	0.00657	0.00657	CcSEcCtD
Phenazopyridine—Dyspepsia—Acitretin—psoriasis	0.00648	0.00648	CcSEcCtD
Phenazopyridine—Visual disturbance—Dexamethasone—psoriasis	0.00639	0.00639	CcSEcCtD
Phenazopyridine—Visual disturbance—Betamethasone—psoriasis	0.00639	0.00639	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Acitretin—psoriasis	0.00636	0.00636	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.00634	0.00634	CcSEcCtD
Phenazopyridine—Hypersensitivity—Calcitriol—psoriasis	0.0061	0.0061	CcSEcCtD
Phenazopyridine—Jaundice—Cyclosporine—psoriasis	0.00599	0.00599	CcSEcCtD
Phenazopyridine—Pruritus—Calcitriol—psoriasis	0.00586	0.00586	CcSEcCtD
Phenazopyridine—Rash—Methoxsalen—psoriasis	0.00586	0.00586	CcSEcCtD
Phenazopyridine—Dermatitis—Methoxsalen—psoriasis	0.00585	0.00585	CcSEcCtD
Phenazopyridine—Jaundice—Mycophenolate mofetil—psoriasis	0.00584	0.00584	CcSEcCtD
Phenazopyridine—Headache—Methoxsalen—psoriasis	0.00582	0.00582	CcSEcCtD
Phenazopyridine—Diarrhoea—Calcitriol—psoriasis	0.00567	0.00567	CcSEcCtD
Phenazopyridine—Nausea—Methoxsalen—psoriasis	0.00552	0.00552	CcSEcCtD
Phenazopyridine—Hepatitis—Cyclosporine—psoriasis	0.00552	0.00552	CcSEcCtD
Phenazopyridine—Hypersensitivity—Acitretin—psoriasis	0.00543	0.00543	CcSEcCtD
Phenazopyridine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00541	0.00541	CcSEcCtD
Phenazopyridine—Hepatitis—Mycophenolate mofetil—psoriasis	0.00538	0.00538	CcSEcCtD
Phenazopyridine—Visual impairment—Cyclosporine—psoriasis	0.00532	0.00532	CcSEcCtD
Phenazopyridine—Vomiting—Calcitriol—psoriasis	0.00526	0.00526	CcSEcCtD
Phenazopyridine—Rash—Calcitriol—psoriasis	0.00522	0.00522	CcSEcCtD
Phenazopyridine—Dermatitis—Calcitriol—psoriasis	0.00522	0.00522	CcSEcCtD
Phenazopyridine—Pruritus—Acitretin—psoriasis	0.00521	0.00521	CcSEcCtD
Phenazopyridine—Pruritus—Fluocinolone Acetonide—psoriasis	0.0052	0.0052	CcSEcCtD
Phenazopyridine—Headache—Calcitriol—psoriasis	0.00519	0.00519	CcSEcCtD
Phenazopyridine—Visual impairment—Mycophenolate mofetil—psoriasis	0.00519	0.00519	CcSEcCtD
Phenazopyridine—Dyspepsia—Hydroxyurea—psoriasis	0.00509	0.00509	CcSEcCtD
Phenazopyridine—Diarrhoea—Acitretin—psoriasis	0.00504	0.00504	CcSEcCtD
Phenazopyridine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00503	0.00503	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00499	0.00499	CcSEcCtD
Phenazopyridine—Nausea—Calcitriol—psoriasis	0.00492	0.00492	CcSEcCtD
Phenazopyridine—Visual impairment—Prednisolone—psoriasis	0.00484	0.00484	CcSEcCtD
Phenazopyridine—Vomiting—Acitretin—psoriasis	0.00468	0.00468	CcSEcCtD
Phenazopyridine—Vomiting—Fluocinolone Acetonide—psoriasis	0.00467	0.00467	CcSEcCtD
Phenazopyridine—Visual disturbance—Methotrexate—psoriasis	0.00465	0.00465	CcSEcCtD
Phenazopyridine—Rash—Acitretin—psoriasis	0.00464	0.00464	CcSEcCtD
Phenazopyridine—Dermatitis—Acitretin—psoriasis	0.00464	0.00464	CcSEcCtD
Phenazopyridine—Rash—Fluocinolone Acetonide—psoriasis	0.00463	0.00463	CcSEcCtD
Phenazopyridine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00463	0.00463	CcSEcCtD
Phenazopyridine—Headache—Acitretin—psoriasis	0.00461	0.00461	CcSEcCtD
Phenazopyridine—Headache—Fluocinolone Acetonide—psoriasis	0.0046	0.0046	CcSEcCtD
Phenazopyridine—Nausea—Acitretin—psoriasis	0.00438	0.00438	CcSEcCtD
Phenazopyridine—Nausea—Fluocinolone Acetonide—psoriasis	0.00436	0.00436	CcSEcCtD
Phenazopyridine—Dyspepsia—Mycophenolic acid—psoriasis	0.00426	0.00426	CcSEcCtD
Phenazopyridine—Hypersensitivity—Hydroxyurea—psoriasis	0.00426	0.00426	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00418	0.00418	CcSEcCtD
Phenazopyridine—Visual impairment—Dexamethasone—psoriasis	0.00404	0.00404	CcSEcCtD
Phenazopyridine—Visual impairment—Betamethasone—psoriasis	0.00404	0.00404	CcSEcCtD
Phenazopyridine—Diarrhoea—Hydroxyurea—psoriasis	0.00396	0.00396	CcSEcCtD
Phenazopyridine—Vomiting—Hydroxyurea—psoriasis	0.00368	0.00368	CcSEcCtD
Phenazopyridine—Rash—Hydroxyurea—psoriasis	0.00365	0.00365	CcSEcCtD
Phenazopyridine—Dermatitis—Hydroxyurea—psoriasis	0.00364	0.00364	CcSEcCtD
Phenazopyridine—Headache—Hydroxyurea—psoriasis	0.00362	0.00362	CcSEcCtD
Phenazopyridine—Dyspepsia—Cyclosporine—psoriasis	0.00345	0.00345	CcSEcCtD
Phenazopyridine—Nausea—Hydroxyurea—psoriasis	0.00344	0.00344	CcSEcCtD
Phenazopyridine—Pruritus—Mycophenolic acid—psoriasis	0.00343	0.00343	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00338	0.00338	CcSEcCtD
Phenazopyridine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00336	0.00336	CcSEcCtD
Phenazopyridine—Diarrhoea—Mycophenolic acid—psoriasis	0.00331	0.00331	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.0033	0.0033	CcSEcCtD
Phenazopyridine—Vomiting—Mycophenolic acid—psoriasis	0.00308	0.00308	CcSEcCtD
Phenazopyridine—Dyspepsia—Hydrocortisone—psoriasis	0.00307	0.00307	CcSEcCtD
Phenazopyridine—Rash—Mycophenolic acid—psoriasis	0.00305	0.00305	CcSEcCtD
Phenazopyridine—Dermatitis—Mycophenolic acid—psoriasis	0.00305	0.00305	CcSEcCtD
Phenazopyridine—Hepatitis—Methotrexate—psoriasis	0.00305	0.00305	CcSEcCtD
Phenazopyridine—Headache—Mycophenolic acid—psoriasis	0.00303	0.00303	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00301	0.00301	CcSEcCtD
Phenazopyridine—Visual impairment—Methotrexate—psoriasis	0.00294	0.00294	CcSEcCtD
Phenazopyridine—Hypersensitivity—Cyclosporine—psoriasis	0.00289	0.00289	CcSEcCtD
Phenazopyridine—Dyspepsia—Triamcinolone—psoriasis	0.00289	0.00289	CcSEcCtD
Phenazopyridine—Nausea—Mycophenolic acid—psoriasis	0.00288	0.00288	CcSEcCtD
Phenazopyridine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00282	0.00282	CcSEcCtD
Phenazopyridine—Pruritus—Cyclosporine—psoriasis	0.00277	0.00277	CcSEcCtD
Phenazopyridine—Pruritus—Mycophenolate mofetil—psoriasis	0.0027	0.0027	CcSEcCtD
Phenazopyridine—Diarrhoea—Cyclosporine—psoriasis	0.00268	0.00268	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisolone—psoriasis	0.00263	0.00263	CcSEcCtD
Phenazopyridine—Dyspepsia—Betamethasone—psoriasis	0.00262	0.00262	CcSEcCtD
Phenazopyridine—Dyspepsia—Dexamethasone—psoriasis	0.00262	0.00262	CcSEcCtD
Phenazopyridine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00262	0.00262	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00257	0.00257	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Betamethasone—psoriasis	0.00257	0.00257	CcSEcCtD
Phenazopyridine—Hypersensitivity—Hydrocortisone—psoriasis	0.00257	0.00257	CcSEcCtD
Phenazopyridine—Vomiting—Cyclosporine—psoriasis	0.00249	0.00249	CcSEcCtD
Phenazopyridine—Rash—Cyclosporine—psoriasis	0.00247	0.00247	CcSEcCtD
Phenazopyridine—Dermatitis—Cyclosporine—psoriasis	0.00247	0.00247	CcSEcCtD
Phenazopyridine—Pruritus—Hydrocortisone—psoriasis	0.00246	0.00246	CcSEcCtD
Phenazopyridine—Headache—Cyclosporine—psoriasis	0.00245	0.00245	CcSEcCtD
Phenazopyridine—Vomiting—Mycophenolate mofetil—psoriasis	0.00243	0.00243	CcSEcCtD
Phenazopyridine—Hypersensitivity—Triamcinolone—psoriasis	0.00242	0.00242	CcSEcCtD
Phenazopyridine—Rash—Mycophenolate mofetil—psoriasis	0.00241	0.00241	CcSEcCtD
Phenazopyridine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00241	0.00241	CcSEcCtD
Phenazopyridine—Headache—Mycophenolate mofetil—psoriasis	0.00239	0.00239	CcSEcCtD
Phenazopyridine—Diarrhoea—Hydrocortisone—psoriasis	0.00238	0.00238	CcSEcCtD
Phenazopyridine—Nausea—Cyclosporine—psoriasis	0.00233	0.00233	CcSEcCtD
Phenazopyridine—Pruritus—Triamcinolone—psoriasis	0.00232	0.00232	CcSEcCtD
Phenazopyridine—Dyspepsia—Prednisone—psoriasis	0.00228	0.00228	CcSEcCtD
Phenazopyridine—Nausea—Mycophenolate mofetil—psoriasis	0.00227	0.00227	CcSEcCtD
Phenazopyridine—Rash—Prednisolone—psoriasis	0.00225	0.00225	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisolone—psoriasis	0.00225	0.00225	CcSEcCtD
Phenazopyridine—Headache—Prednisolone—psoriasis	0.00223	0.00223	CcSEcCtD
Phenazopyridine—Vomiting—Hydrocortisone—psoriasis	0.00221	0.00221	CcSEcCtD
Phenazopyridine—Rash—Hydrocortisone—psoriasis	0.0022	0.0022	CcSEcCtD
Phenazopyridine—Dermatitis—Hydrocortisone—psoriasis	0.00219	0.00219	CcSEcCtD
Phenazopyridine—Headache—Hydrocortisone—psoriasis	0.00218	0.00218	CcSEcCtD
Phenazopyridine—Nausea—Prednisolone—psoriasis	0.00212	0.00212	CcSEcCtD
Phenazopyridine—Pruritus—Betamethasone—psoriasis	0.00211	0.00211	CcSEcCtD
Phenazopyridine—Pruritus—Dexamethasone—psoriasis	0.00211	0.00211	CcSEcCtD
Phenazopyridine—Vomiting—Triamcinolone—psoriasis	0.00208	0.00208	CcSEcCtD
Phenazopyridine—Nausea—Hydrocortisone—psoriasis	0.00207	0.00207	CcSEcCtD
Phenazopyridine—Rash—Triamcinolone—psoriasis	0.00207	0.00207	CcSEcCtD
Phenazopyridine—Dermatitis—Triamcinolone—psoriasis	0.00207	0.00207	CcSEcCtD
Phenazopyridine—Headache—Triamcinolone—psoriasis	0.00205	0.00205	CcSEcCtD
Phenazopyridine—Diarrhoea—Dexamethasone—psoriasis	0.00204	0.00204	CcSEcCtD
Phenazopyridine—Diarrhoea—Betamethasone—psoriasis	0.00204	0.00204	CcSEcCtD
Phenazopyridine—Nausea—Triamcinolone—psoriasis	0.00195	0.00195	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisone—psoriasis	0.00191	0.00191	CcSEcCtD
Phenazopyridine—Dyspepsia—Methotrexate—psoriasis	0.00191	0.00191	CcSEcCtD
Phenazopyridine—Vomiting—Dexamethasone—psoriasis	0.00189	0.00189	CcSEcCtD
Phenazopyridine—Vomiting—Betamethasone—psoriasis	0.00189	0.00189	CcSEcCtD
Phenazopyridine—Rash—Betamethasone—psoriasis	0.00188	0.00188	CcSEcCtD
Phenazopyridine—Rash—Dexamethasone—psoriasis	0.00188	0.00188	CcSEcCtD
Phenazopyridine—Dermatitis—Dexamethasone—psoriasis	0.00187	0.00187	CcSEcCtD
Phenazopyridine—Dermatitis—Betamethasone—psoriasis	0.00187	0.00187	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Methotrexate—psoriasis	0.00187	0.00187	CcSEcCtD
Phenazopyridine—Headache—Betamethasone—psoriasis	0.00186	0.00186	CcSEcCtD
Phenazopyridine—Headache—Dexamethasone—psoriasis	0.00186	0.00186	CcSEcCtD
Phenazopyridine—Pruritus—Prednisone—psoriasis	0.00183	0.00183	CcSEcCtD
Phenazopyridine—Diarrhoea—Prednisone—psoriasis	0.00177	0.00177	CcSEcCtD
Phenazopyridine—Nausea—Betamethasone—psoriasis	0.00177	0.00177	CcSEcCtD
Phenazopyridine—Nausea—Dexamethasone—psoriasis	0.00177	0.00177	CcSEcCtD
Phenazopyridine—Vomiting—Prednisone—psoriasis	0.00165	0.00165	CcSEcCtD
Phenazopyridine—Rash—Prednisone—psoriasis	0.00163	0.00163	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisone—psoriasis	0.00163	0.00163	CcSEcCtD
Phenazopyridine—Headache—Prednisone—psoriasis	0.00162	0.00162	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methotrexate—psoriasis	0.0016	0.0016	CcSEcCtD
Phenazopyridine—Nausea—Prednisone—psoriasis	0.00154	0.00154	CcSEcCtD
Phenazopyridine—Pruritus—Methotrexate—psoriasis	0.00153	0.00153	CcSEcCtD
Phenazopyridine—Diarrhoea—Methotrexate—psoriasis	0.00148	0.00148	CcSEcCtD
Phenazopyridine—Vomiting—Methotrexate—psoriasis	0.00138	0.00138	CcSEcCtD
Phenazopyridine—Rash—Methotrexate—psoriasis	0.00137	0.00137	CcSEcCtD
Phenazopyridine—Dermatitis—Methotrexate—psoriasis	0.00136	0.00136	CcSEcCtD
Phenazopyridine—Headache—Methotrexate—psoriasis	0.00136	0.00136	CcSEcCtD
Phenazopyridine—Nausea—Methotrexate—psoriasis	0.00129	0.00129	CcSEcCtD
